995. Safety and Efficacy of F/TAF and F/TDF for PrEP in DISCOVER Participants Taking F/TDF for PrEP at Baseline

por Campbell, Thomas, Clarke, Amanda, Trottier, Benoit, Carter, Christoph C, Shao, Yongwu, Ebrahimi, Ramin, Das, Moupali, Brainard, Diana M, Gladstein, Jay
Publicado 2020

985. Impact of Age and Medical Comorbidities on Renal Outcomes in the DISCOVER Trial

por Daar, Eric, Brunetta, Jason, Cua, Eric, Flamm, Jason, Asmuth, David, Carter, Christoph C, Shao, Yongwu, Wong, Pamela, Ebrahimi, Ramin, Das, Moupali, Brainard, Diana M, Clarke, Amanda
Publicado 2020

Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation

por Perez-Valero, Ignacio, Llibre, Josep M., Castagna, Antonella, Pulido, Federico, Molina, Jean-Michel, Esser, Stefan, Margot, Nicolas, Shao, Yongwu, Temme, Lauren, Piontkowsky, David, McNicholl, Ian R., Haubrich, Richard
Publicado 2021

An IL28B Genotype-Based Clinical Prediction Model for Treatment of Chronic Hepatitis C

por O'Brien, Thomas R., Everhart, James E., Morgan, Timothy R., Lok, Anna S., Chung, Raymond T., Shao, Yongwu, Shiffman, Mitchell L., Dotrang, Myhanh, Sninsky, John J., Bonkovsky, Herbert L., Pfeiffer, Ruth M.
Publicado 2011